Sonovol, Inc.

Durham, NC · Medtech · Acquired

Robotically controlled volumetric ultrasound elastography imaging platform for noninvasive assessment of renal fibrosis in rodent models

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · sonovol.com

Sector: Medtech
Headquarters: Durham, NC
Total capital: $11.4M

Federal grants: $11.4M; 19 awards · 2015–2022; Rank in peer group#39 of 538
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 1; 3 pending · first 2022; Rank in peer group#237 of 538

Capital timeline

Latest events

Aug 2022Federal grantHealth and Human S · Phase II · A turnkey research platform to accelerate clinical translation of targeted immune-modulation enhanced therapies$762K
Jul 2021Federal grantHealth and Human S · Phase II · A turnkey research platform to accelerate clinical translation of targeted immune-modulation enhanced therapies$1.2M
Sep 2020Federal grantHealth and Human S · Phase I · A new robotic AI imaging platform for improved kidney disease research and drug discovery$300K
Jul 2020Federal grantHealth and Human S · Phase II · Whole-organ bioreactor with integrated nondestructive 3D molecular imaging$907K
Sep 2019Federal grantHealth and Human S · Phase I · A turnkey research platform to accelerate clinical translation of focused-ultrasound (FUS) oncology therapies$300K
Jul 2019Federal grantHealth and Human S · Phase II · Whole-organ bioreactor with integrated nondestructive 3D molecular imaging$1.1M
Jul 2019Federal grantHealth and Human S · Phase II · A preclinical multi-modal system for dynamic noninvasive assessment of liver disease$152K

Show 12 earlier federal awards

Jul 2019Federal grantHealth and Human S · Phase I · Development of a Longitudinal Molecular Imaging Platform to Support Immuno-Oncology Research$244K
Apr 2019Federal grantHealth and Human S · Phase II · A preclinical multi-modal system for dynamic noninvasive assessment of liver disease$827K
Apr 2019Federal grantHealth and Human S · Phase II · Development of a mobile and automated platform for multiplexed multi-modality imaging$210K
Apr 2018Federal grantHealth and Human S · Phase II · A preclinical multi-modal system for dynamic noninvasive assessment of liver disease$896K
Feb 2018Federal grantHealth and Human S · Phase II · Development of a mobile and automated platform for multiplexed multi-modality imaging$932K
Sep 2017Federal grantHealth and Human S · Phase I · A noninvasive method for tissue stiffness quantification in small animals with shear wave elastography$30K
Aug 2017Federal grantHealth and Human S · Phase II · Whole-organ bioreactor with integrated nondestructive 3D molecular imaging$225K
Mar 2017Federal grantHealth and Human S · Phase II · Development of a mobile and automated platform for multiplexed multi-modality imaging$1.1M
Sep 2016Federal grantHealth and Human S · Phase I · A noninvasive method for tissue stiffness quantification in small animals with shear wave elastography$225K
Mar 2016Federal grantHealth and Human S · Phase I · Development of an ultrasound-optical hybrid modality preclinical imaging tool$40K
Sep 2015Federal grantNSF · Phase II · SBIR Phase II: Developing a new platform technology for 3D ultrasound imaging$898K
Apr 2015Federal grantHealth and Human S · Phase I · Development of an ultrasound-optical hybrid modality preclinical imaging tool$1M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

Federal grants#39 · top 7%
Granted patents#237 · top 44%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 4

Apr 19, 2022GrantedApparatuses, Systems, And Methods For Preclinical Ultrasound Imaging Of SubjectsUSPTOUS 11,304,676
Aug 8, 2019PendingSystem And Method For Noninvasively Assessing Bioengineered OrgansUSPTOApplication 16327726
PendingSystem And Method For Noninvasively Assessing Bioengineered OrgansUSPTOApplication PCTUS2017050076

Show all 4 patent records

Apparatuses, Systems, And Methods For Preclinical Ultrasound Imaging Of SubjectsApr 19, 2022 · US 11,304,676Granted
System And Method For Noninvasively Assessing Bioengineered OrgansAug 8, 2019 · Application 16327726Pending
System And Method For Noninvasively Assessing Bioengineered OrgansApplication PCTUS2017050076Pending
System And Method For Noninvasively Assessing Bioengineered OrgansApplication 62383068Pending

SonoVol, LLCShares a founder: RYAN GESSNER
UAS ASSOCIATES LLCSimilar federal contract value in Medtech · null in contracts
INNOVATIONS IN SAFETY, LLCSimilar federal contract value in Medtech · null in contracts
NeuroPsyCADSimilar federal contract value in Medtech · null in contracts
BIOSYFT INC.Similar federal contract value in Medtech · null in contracts
Soterya, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.